Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Toxicol Environ Health A ; 82(4): 233-243, 2019.
Article in English | MEDLINE | ID: mdl-30821635

ABSTRACT

Inhalation of organic dust or endotoxin in the dust is considered a major risk factor for occupational respiratory illnesses. Eighteen environmental characteristics associated with animal husbandry were surveyed at 36 swine farms in seven provinces throughout South Korea. Association of these factors with levels of indoor inhalable or respirable dust or endotoxin in each type of dust was analyzed using backward stepwise multiple linear regression models. Mean levels of inhalable and respirable dust were 0.5 ± 0.35 and 0.13 ± 0.12 mg/m3 air, respectively, and mean endotoxin levels were 676 ± 463 and 48.4 ± 68.2 EU/m3, respectively, in each dust. Factors negatively associated with inhalable dust levels included pig age, indoor farm temperature, number of pigs in the building, hr/week of indoor farm work, and partly slatted floor. Factors positively associated with inhalable dust levels included floor cleaning by manual scraping and slurry deposit duration. Factors negatively associated with the level of endotoxin in inhalable dust included pig age, temperature, number of pigs, hr/week of indoor farm work, and partly slatted floor. Factors negatively associated with respirable dust level included area of the confinement building, whereas factors positively associated with respirable dust level included the number of pigs and stocking density. Endotoxin levels in respirable dust were negatively associated with h/week of indoor farm work and partly slatted floor. Overall, data suggest that husbandry variables may be adjusted to control dust and airborne endotoxin levels in swine farms.


Subject(s)
Air Pollutants, Occupational/analysis , Air Pollution, Indoor/analysis , Animal Husbandry/statistics & numerical data , Dust/analysis , Endotoxins/analysis , Inhalation Exposure/analysis , Occupational Exposure/analysis , Adult , Animals , Female , Humans , Male , Middle Aged , Republic of Korea , Swine
2.
J Nanobiotechnology ; 9: 57, 2011 Dec 08.
Article in English | MEDLINE | ID: mdl-22152062

ABSTRACT

BACKGROUND: Light-directed in situ synthesis of DNA microarrays using computer-controlled projection from a digital micromirror device--maskless array synthesis (MAS)--has proved to be successful at both commercial and laboratory scales. The chemical synthetic cycle in MAS is quite similar to that of conventional solid-phase synthesis of oligonucleotides, but the complexity of microarrays and unique synthesis kinetics on the glass substrate require a careful tuning of parameters and unique modifications to the synthesis cycle to obtain optimal deprotection and phosphoramidite coupling. In addition, unintended deprotection due to scattering and diffraction introduce insertion errors that contribute significantly to the overall error rate. RESULTS: Stepwise phosphoramidite coupling yields have been greatly improved and are now comparable to those obtained in solid phase synthesis of oligonucleotides. Extended chemical exposure in the synthesis of complex, long oligonucleotide arrays result in lower--but still high--final average yields which approach 99%. The new synthesis chemistry includes elimination of the standard oxidation until the final step, and improved coupling and light deprotection. Coupling Insertions due to stray light are the limiting factor in sequence quality for oligonucleotide synthesis for gene assembly. Diffraction and local flare are by far the largest contributors to loss of optical contrast. CONCLUSIONS: Maskless array synthesis is an efficient and versatile method for synthesizing high density arrays of long oligonucleotides for hybridization- and other molecular binding-based experiments. For applications requiring high sequence purity, such as gene assembly, diffraction and flare remain significant obstacles, but can be significantly reduced with straightforward experimental strategies.


Subject(s)
Oligonucleotide Array Sequence Analysis/methods , Oligonucleotides/chemical synthesis , Solid-Phase Synthesis Techniques/methods , Base Sequence , Glass/chemistry , Kinetics , Nucleic Acid Hybridization , Photochemistry/methods
3.
Org Lett ; 8(11): 2357-60, 2006 May 25.
Article in English | MEDLINE | ID: mdl-16706525

ABSTRACT

[reaction: see text] We report the development of a safety-catch photolabile linker that allows the light-directed synthesis and spatially selective photorelease of oligonucleotides from microarrays. The linker remains stable to light during DNA synthesis, and is activated for photorelease after acidic hydrolysis. We demonstrate that the photoreleased oligonucleotides can be amplified by PCR to produce double stranded DNA. The advantages offered by this linker could aid the development of an automated gene synthesis platform.


Subject(s)
DNA/chemical synthesis , Oligonucleotides/chemical synthesis , Photolysis , DNA/chemistry , Molecular Structure , Oligonucleotides/chemistry
4.
J Ethnopharmacol ; 97(3): 509-13, 2005 Mar 21.
Article in English | MEDLINE | ID: mdl-15740888

ABSTRACT

Benincasa hispida in Korea was used mainly diabetes and diuresis diseases. This study was carried out to evaluate anti-angiogenic effect of the seed extract of Benincasa hispida Cogniaux. Basic fibroblast growth factor (bFGF) is a potent angiogenic factor found in various tumors. In this study, we found that the seed extract of Benincasa hispida Cogniaux decreased bFGF-induced endothelial cell proliferation and tube formation in a dose-dependent manner. Besides, Benincasa hispida seed extract showed no cytotoxicity on HUVECs and normal fibroblast cells. Furthermore, the seed extract of Benincasa hispida showed a potent inhibitory effect on bFGF-induced angiogenesis in vivo. These results suggest that the seed extract of Benincasa hispida inhibits the proliferation of endothelial cells induced by bFGF, which may explain its anti-angiogenic properties.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Cucurbitaceae , Endothelium, Vascular/drug effects , Angiogenesis Inhibitors/isolation & purification , Animals , Cells, Cultured , Endothelium, Vascular/physiology , Humans , Male , Mice , Mice, Inbred C57BL , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Seeds
5.
J Am Chem Soc ; 126(51): 16704-5, 2004 Dec 29.
Article in English | MEDLINE | ID: mdl-15612691

ABSTRACT

We describe the development of photolabile protecting groups based on the 3,4,5-trimethoxyphenacyl group (TMP). Orthogonal safety-catches were created by introducing an acid-activatible dimethyl ketal (AA-TMP) and an oxidatively activatible 1,3-dithiane (OA-TMP) into the photolabile TMP group. We demonstrate the application of these protecting groups in light-directed synthesis of small molecule microarrays with diversity elements radially attached to a hydroxyproline scaffold.


Subject(s)
Acetophenones/chemistry , Combinatorial Chemistry Techniques/methods , Microarray Analysis/methods , Benzoin/chemistry , Hydroxyproline/chemistry , Photolysis
6.
Nucleic Acids Res ; 32(17): 5011-8, 2004.
Article in English | MEDLINE | ID: mdl-15448182

ABSTRACT

A basic problem in gene synthesis is the acquisition of many short oligonucleotide sequences needed for the assembly of genes. Photolithographic methods for the massively parallel synthesis of high-density oligonucleotide arrays provides a potential source, once appropriate methods have been devised for their elution in forms suitable for enzyme-catalyzed assembly. Here, we describe a method based on the photolithographic synthesis of long (>60mers) single-stranded oligonucleotides, using a modified maskless array synthesizer. Once the covalent bond between the DNA and the glass surface is cleaved, the full-length oligonucleotides are selected and amplified using PCR. After cleavage of flanking primer sites, a population of unique, internal 40mer dsDNA sequences are released and are ready for use in biological applications. Subsequent gene assembly experiments using this DNA pool were performed and were successful in creating longer DNA fragments. This is the first report demonstrating the use of eluted chip oligonucleotides in biological applications such as PCR and assembly PCR.


Subject(s)
Genes , Oligodeoxyribonucleotides/biosynthesis , Oligonucleotide Array Sequence Analysis/methods , Polymerase Chain Reaction , Oligodeoxyribonucleotides/chemistry , Oligodeoxyribonucleotides/isolation & purification
7.
Chemotherapy ; 49(5): 257-63, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14504438

ABSTRACT

To investigate the enzyme-inhibitory efficacy and the cytotoxicity of reticulol produced from a strain of Streptoverticillium, we conducted a DNA topoisomerase (Topo) cleavage assay and an in vivo assay using B16F10 melanoma. From the inhibition assay of reticulol for Topo I, which is involved in melanoma metastasis, it was seen that Topo I treated with 45 microM reticulol did not replicate or transcribe DNA by forming supercoiled DNA. In the annexin V/propidium iodide staining assay to investigate the death pattern of B16F10 cells treated with 200 microM reticulol, proliferation of B16F10 cells was inhibited due to necrosis. Furthermore, from the in vivo assay, reticulol combined with Adriamycin (a mixture with retinolol 5 mg/kg and Adriamycin 1 mg/kg) further retarded the tumor growth compared to that in mice treated with Adriamycin alone (1 mg/kg). The survival rate of tumor-bearing mice treated with the mixture was closely associated with its cytotoxicity. Taken together, these results suggested that reticulol inactivates Topo I, which is involved in tumor metastasis, and exhibits excellent cytotoxic efficacy against B16F10 melanoma, when combined with Adriamycin, in a mouse model.


Subject(s)
Coumarins/pharmacology , Melanoma, Experimental/drug therapy , Phosphodiesterase Inhibitors/pharmacology , Skin Neoplasms/drug therapy , Topoisomerase I Inhibitors , Animals , Antibiotics, Antineoplastic/pharmacology , Antibiotics, Antineoplastic/therapeutic use , Cell Line, Tumor , Coumarins/administration & dosage , Coumarins/therapeutic use , DNA Topoisomerases, Type I/metabolism , Doxorubicin/pharmacology , Doxorubicin/therapeutic use , Drug Therapy, Combination , Female , Injections, Intravenous , Isocoumarins , Melanoma, Experimental/enzymology , Melanoma, Experimental/secondary , Mice , Mice, Inbred C57BL , Neoplasm Metastasis , Phosphodiesterase Inhibitors/administration & dosage , Phosphodiesterase Inhibitors/therapeutic use , Skin Neoplasms/enzymology , Skin Neoplasms/pathology
8.
Chemotherapy ; 49(3): 146-53, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12815208

ABSTRACT

Reticulol was isolated from the culture broth of the strain Streptoverticillium sp. NA-4803. Recticulol (M.W. 222.2) exhibited a potent in vitro cytotoxicity against A427, a human lung tumor cell line, and B16F10, a mouse melanoma cell line. In the trypan blue staining assay for B16F10 cells, the cell viability by reticulol treatment was significantly decreased in a dose-dependent manner. The in vivo assay for the lung metastasis-blocking effect showed that reticulol injected intravenously suppressed the increase in colonies on the lung in a dose-dependent manner. In addition, the survival rate of tumor-implanted mice treated with reticulol was closely associated with its antitumoral efficacy. Reticulol administered via the peritoneum of mice showed less metastasis inhibition than that injected intravenously. To demonstrate the mechanism for inhibition of metastasis, the inhibitory effect of reticulol for matrix metalloproteinase-2 or -9 involved in melanoma metastasis was investigated; however, they were not observed on zymogram gel. In addition, the antitumor efficacy of reticulol was not associated with cell cycle arrest or apoptosis. Therefore, it was inferred that reticulol known as a phosphodiesterase inhibitor directly inhibited the growth of B16F10 melanoma, showing necrotic response. These results suggest that reticulol protects its lung metastasis via the bloodstream by inhibiting the growth of B16F10 melanoma at the cellular level.


Subject(s)
Coumarins/pharmacology , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Melanoma/pathology , 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , Animals , Coumarins/administration & dosage , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Infusions, Parenteral , Injections, Intravenous , Isocoumarins , Lung Neoplasms/veterinary , Melanoma/veterinary , Mice , Mice, Inbred C57BL , Necrosis , Neoplasms, Experimental
SELECTION OF CITATIONS
SEARCH DETAIL
...